Deal Of The Week: Will Heated Competition To Buy Out Ache Laboratorios Muddy The Brazilian Waters?

Could a bidding war for Brazil’s privately held Ache Laboratorios do for Latin America what Abbott Laboratories Inc.’s gargantuan purchase of part of India’s Piramal Enterprises Ltd. did for biopharma M&A in India?

Call it the “Piramal effect,” if you will. Abbott reset expectations among India’s domestic pharma world with its $3.72 billion purchase in 2010 of Piramal’s branded generics business Also see "Abbott's Piramal Acquisition Is $3.72 Billion Push In Emerging Markets With Established Products" - Scrip, 21 May, 2010.